Image

The Impact of Low Glycemic Index Nutritional Shake on Glucose Regulation in Overweight and Obese Adults

The Impact of Low Glycemic Index Nutritional Shake on Glucose Regulation in Overweight and Obese Adults

Recruiting
25-65 years
All
Phase N/A

Powered by AI

Overview

Low glycemic index nutritional shakes have clinically shown to improve post-prandial glycemic responses in acute laboratory control studies. However, there is limited information on how replacing meals with low-glycemic index shake could impact glucose regulation in free-living adults consuming their own diets.

The present study aims to examine the impact of adding the SP Glucose-Assist shake to the breakfast of non-diabetic overweight and obese adults.

Subjects

40 non-diabetic adults aged 25-65 years and body mass index ranging between 25-39 .

Protocol

This is going to be a three-week study that will include a one-week self-selected diet, followed by two weeks of a breakfast supplement shake (standard process glucose assist) or control cereal oat breakfast.

Eligibility

Inclusion Criteria:

  • Body mass index 25-40
  • Eating pattern 3 meals a day
  • stable weight for the last 2 months (<5 pounds fluctuation)
  • Willing to eat oat cereal for breakfast
  • glycated hemoglobin <7%

Exclusion Criteria:

  • glycated hemoglobin >7%
  • Body mass index ≤25 or ≥ 40
  • Night shifting work
  • Atypical meal pattern (not three meals a day or intermittent fasting)
  • Thyroid medication
  • Bariatric surgery
  • Habitual strenuous exercise
  • Commuting by bicycle
  • Eating disorders
  • Use of aspirin during the duration of the study
  • Intake of Vit C >60 mg/day during the study
  • cancer
  • cardiovascular disease
  • renal disease
  • hepatic disease
  • X-ray, MRI or CT appointment during the study duration
  • Current infection requiring medication
  • Chronic, contagious, infectious diseases such as tuberculosis, Hepatitis A, B, C, or HIV
  • Medications of supplements that could affect body weight or appetite (i.e. Ozempic)
  • Participating in another study at the same time

Study details
    Hyperglycemia
    Obesity Prevention

NCT06856460

Arizona State University

25 August 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.